Sam Slutsky
Analyst
LifeSci Capital
Equibles does not estimate personal net worth.
About Sam Slutsky
Sam Slutsky is recorded as Analyst at LifeSci Capital. Sam Slutsky has spoken on 2 earnings calls across 2 companies, most recently for Oruka Therapeutics, Inc. on April 30, 2026. Those appearances were for Oruka Therapeutics, Inc. (ORKA) and DBV Technologies S.A. (DBVT). The companies whose calls Sam Slutsky spoke on are classified in the Healthcare sector.
Sam Slutsky on recent calls
“Just a quick one for me, just based on these results there's a few angles for development and commercialization that you could take with 001, whether it's a 6-versus-12-month dosing interval and then in-clinic versus at-home sub-q dosing.”
“I guess on the approval process, what has to be done between now and BLA filing? Also, any recent conversations with the FDA that are notable, just given some of the personal changes they've had at the agency?”
Affiliation history
-
LifeSci Capital
Analyst
Transcript header (unverified)
Current